Teva API (TAPI) is a leading global supplier of active pharmaceutical ingredients (APIs), operating as both a Contract Development and Manufacturing Organisation (CDMO) and a genetic API player. As a standalone business unit of Teva Pharmaceutical Industries, TAPI excels in the development, production, and supply of high-quality APIs to pharmaceutical companies around the globe. Their steadfast commitment to innovation and quality significantly aids these companies in the creation and distribution of effective medications for patients worldwide.

Services include:
- Small Molecule, Drug Substance Manufacturing (API)
- Peptide Manufacturing
- Oligonucleotide Manufacturing
- Fermentation
- High Potency Manufacturing
- Plant Extraction

Teva API’s broad portfolio encompasses over 350 different API products, establishing it as one of the largest suppliers in the industry. With a global reach that serves more than 1,000 customers across over 100 countries, TAPI’s expertise in various technologies, combined with its stringent adherence to quality and regulatory compliance, ensures that its products meet the highest international standards. Readers are encouraged to find more information at teva.co.il.